Tumor necrosis factor-like weak inducer of apoptosis induces astrocyte proliferation through the activation of transforming-growth factor-α/ epidermal growth factor receptor signaling pathway

Molecular Pharmacology

Volumn 82, Issue 5, 2012, Pages 948-957

  Rousselet, Estelle ^a,b,c   Traver, Sabine ^a,b,c   Monnet, Yann ^a,b,c   Perrin, Aline ^a,b,c   Mandjee, Nathalie ^a,b,c   Hild, Audrey ^a,b,c   Hirsch, Etienne C ^a,b,c   Zheng, Timothy S ^d   Hunot, Steṕhane ^a,b,c  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL POPULATION; CELL PROLIFERATION; EMBRYO; ENZYME ACTIVATION; IN VITRO STUDY; MICROGLIA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; CELL PROLIFERATION; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEINS; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTORS;

EID: 84867817864     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.079608     Document Type: Article

References (56)

1. Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, et al. (2006) TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8:R146.
2. Brown SA, Ghosh A, and Winkles JA (2010) Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-κB pathway. J Biol Chem 285:17432-17441.
3. Brown SA, Hanscom HN, Vu H, Brew SA, and Winkles JA (2006) TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules. Biochem J 397:297-304. (Pubitemid 44076899)
4. Brown SA, Richards CM, Hanscom HN, Feng SL, and Winkles JA (2003) The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation. Biochem J 371:395-403. (Pubitemid 36547622)
5. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, and Browning JL (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401-32410. (Pubitemid 28011923)
6. Dai L, Gu L, Ding C, Qiu L, and Di W (2009) TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression. Cancer Lett 283:159-167.
7. Desplat-Jégo S, Creidy R, Varriale S, Allaire N, Luo Y, Bernard D, Hahm K, Burkly L, and Boucraut J (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol 117:15-23. (Pubitemid 41725465)
8. Desplat-Jégo S, Feuillet L, Creidy R, Malikova I, Rance R, Khrestchatisky M, Hahm K, Burkly LC, Pelletier J, and Boucraut J (2009) TWEAK is expressed at the cell surface of monocytes during multiple sclerosis. J Leukoc Biol 85:132-135.
9. Desplat-Jégo S, Varriale S, Creidy R, Terra R, Bernard D, Khrestchatisky M, Izui S, Chicheportiche Y, and Boucraut J (2002) TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133:116-123. (Pubitemid 35346733)
10. + requires concurrent inactivation of NMDA or AMPA/kainate receptors. J Neurochem 78:163-174.
11. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683-2710. (Pubitemid 350070717)
12. Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, et al. (1996) Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 7:147-160. (Pubitemid 26049823)
13. Haile WB, Echeverry R, Wu F, Guzman J, An J, Wu J, and Yepes M (2010) Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Neuroscience 171:1256-1264.
14. Hamill CA, Michaelson JS, Hahm K, Burkly LC, and Kessler JA (2007) Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells. J Neurosci Res 85:3535-3544. (Pubitemid 350228699)
15. Han S, Yoon K, Lee K, Kim K, Jang H, Lee NK, Hwang K, and***Young Lee S (2003) TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-κB through TNF receptor-associated factors. Biochem Biophys Res Commun 305:789-796. (Pubitemid 36597832)
16. Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, and Yamamoto T (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res 254:14-24. (Pubitemid 30066727)
17. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed., Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
18. Inta I, Frauenknecht K, Dörr H, Kohlhof P, Rabsilber T, Auffarth GU, Burkly L, Mittelbronn M, Hahm K, Sommer C, et al. (2008) Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke. J Neurol Sci 275:117-120.
19. Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, and Ting JP (2008) TNF Superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. J Neuroimmunol 194:97-106.
20. Kawamoto JC and Barrett JN (1986) Cryopreservation of primary neurons for tissue culture. Brain Res 384:84-93. (Pubitemid 16001357)
21. Kniss DA and Burry RW (1988) Serum and fibroblast growth factor stimulate quiescent astrocytes to re-enter the cell cycle. Brain Res 439:281-288. (Pubitemid 18065714)
22. Kornblum HI, Zurcher SD, Werb Z, Derynck R, and Seroogy KB (1999) Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur J Neurosci 11:3236-3246. (Pubitemid 29431658)
23. Kumar M, Makonchuk DY, Li H, Mittal A, and Kumar A (2009) TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-β-activated kinase 1. J Immunol 182:2439-2448.
24. Leutz A and SchachnerM(1981) Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures. Cell Tissue Res 220:393-404. (Pubitemid 12206424)
25. Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, and Wiley SR (1999) TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274:8455-8459. (Pubitemid 29164634)
26. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, et al. (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a CDNA microarray analysis. J Neurooncol 53:161-176. (Pubitemid 33034689)
27. Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, and Ashkenazi A (1998) Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 8:525-528. (Pubitemid 28203072)
28. Michel PP, Ruberg M, and Agid Y (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 69:1499-1507. (Pubitemid 27406951)
29. Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, et al. (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. J Am Soc Nephrol 22:1315-1325.
30. Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanda AM, Donehower LA, and Berger M (1994) Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol 18:207-216. (Pubitemid 24209422)
31. Pekny M and Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50: 427-434. (Pubitemid 40780846)
32. Polavarapu R, Gongora MC, Winkles JA, and Yepes M (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-κB pathway activation. J Neurosci 25:10094-10100. (Pubitemid 41636205)
33. Potrovita I, Zhang W, Burkly L, Hahm K, Lincecum J, Wang MZ, Maurer MH, Rossner M, Schneider A, and Schwaninger M (2004) Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration. J Neurosci 24:8237-8244. (Pubitemid 39280803)
34. Presta M, Rusnati M, Urbinati C, Tanghetti E, Statuto M, Pozzi A, Gualandris A, and Ragnotti G (1992) Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells. EXS 61:205-209.
35. Rakic P (1991) Glial cells in development. In vivo and in vitro approaches. Ann NY Acad Sci 633:96-99.
36. Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, and Dietrich PY (2000) TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 32:102-107.
37. Santiskulvong C, Sinnett-Smith J, and Rozengurt E (2001) EGF receptor function is required in late G1 for cell cycle progression induced by bombesin and bradykinin. Am J Physiol Cell Physiol 281:C886-C898.
38. Sanz AB, Sanchez-Niño MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM, Ruiz-Ortega M, Egido J, and Ortiz A (2009) Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J Cell Mol Med 13:3329-3342.
39. Sanz AB, Sanchez-Niño MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM, Ruiz-Ortega M, Selgas R, Egido J, and Ortiz A (2010) TWEAK activates the non-canonical NFκB pathway in murine renal tubular cells: modulation of CCL21. PLoS One 5:e8955.
40. Sanz-Moreno V, Casar B, and Crespo P (2003) p38α isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol Cell Biol 23:3079-3090. (Pubitemid 36459223)
41. Schölzke MN, Rōttinger A, Murikinati S, Gehrig N, Leib C, and Schwaninger M (2011) TWEAK Regulates Proliferation and Differentiation of Adult Neural Progenitor Cells. Mol Cell Neurosci 46:325-332.
42. Serafini B, Magliozzi R, Rosicarelli B, Reynolds R, Zheng TS, and Aloisi F (2008) Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury. J Neuropathol Exp Neurol 67:1137-1148.
43. Sharif A, Prévot V, Renault-Mihara F, Allet C, Studler JM, Canton B, Chneiweiss H, and Junier MP (2006) Transforming growth factor α acts as a gliatrophin for mouse and human astrocytes. Oncogene 25:4076-4085. (Pubitemid 44024870)
44. Tanabe K, Bonilla I, Winkles JA, and Strittmatter SM (2003) Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 23:9675-9686. (Pubitemid 37352067)
45. Taylor TE, Furnari FB, and Cavenee WK (2012) Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets 12:197-209.
46. Théry C, Chamak B, and Mallat M (1991) Cytotoxic effect of brain macrophages on developing. Eur J Neurosci 3:1155-1164.
47. Thorsen VA, Vorland M, Bjørndal B, Bruland O, Holmsen H, and Lillehaug JR (2003) Participation of phospholipase D and α/β-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts. Biochim Biophys Acta 1632:62-71. (Pubitemid 36628117)
48. Tran NL, McDonough WS, Donohue PJ, Winkles JA, Berens TJ, Ross KR, Hoelzinger DB, Beaudry C, Coons SW, and Berens ME (2003) The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol 162:1313-1321. (Pubitemid 36350675)
49. Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, Symons M, Nakada M, Cunliffe HE, Hostetter G, Hoelzinger DB, et al. (2006) Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome. Cancer Res 66: 9535-9542. (Pubitemid 44623652)
50. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, and Berens ME (2005) The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 280:3483-3492. (Pubitemid 40223813)
51. Vendrell J, Maymó-Masip E, Tinahones F, García-España A, Megia A, Caubet E, García-Fuentes E, and Chacón MR (2010) Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab 95:2983-2992.
52. Voelzke WR, Petty WJ, and Lesser GJ (2008) Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr Treat Options Oncol 9:23-31.
53. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, and Fanslow WC (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837-846. (Pubitemid 34008510)
54. Wiley SR and Winkles JA (2003) TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 14:241-249. (Pubitemid 36693144)
55. Zhang H, Chalothorn D, Jackson LF, Lee DC, and Faber JE (2004) Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle. Circ Res 95:989-997. (Pubitemid 39532329)
56. Zhang W and Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9-18.